×
About 1,365 results

ALLMedicine™ Zollinger-Ellison Syndrome Center

Research & Reviews  86 results

A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell...
https://doi.org/10.1007/s12328-021-01581-6 10.1016/0016-5085(93)90266-F 10.1007/BF02739887 10.1097/01.pas.0000163363.86099.9f 10.1007/s00595-009-4032-7 10.1016/j.gie.2019.06.029 10.1677/ERC-07-0251
Clinical Journal of Gastroenterology; Hirai R, Haruma K et. al.

Jan 5th, 2022 - We report here a case of a 62-year-old woman with multiple gastric enterochromaffin-like cell neuroendocrine tumor caused by hypergastrinemia due to parietal cell dysfunction that was successfully treated with somatostatin analogue. Esophagogastro...

Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475006
World Journal of Gastroenterology; Rossi RE, Elvevi A et. al.

Oct 12th, 2021 - Zollinger-Ellison syndrome (ZES) associated with pancreatic or duodenal gastrinoma is characterized by gastric acid hypersecretion, which typically leads to gastroesophageal reflux disease, recurrent peptic ulcers, and chronic diarrhea. As symptom...

Validity of Secretin Stimulation Testing on Proton Pump Inhibitor Therapy for Diagnosis...
https://doi.org/10.14309/ajg.0000000000001487
The American Journal of Gastroenterology; Bhattacharya S, Blau JE et. al.

Sep 14th, 2021 - Zollinger-Ellison syndrome (ZES) is characterized by gastrinoma-induced hypergastrinemia causing excessive gastric acid secretion. Secretin stimulation tests (SSTs) are required for diagnosis in the majority of patients. Two case reports suggest t...

Successful endoscopic resection of an unusually enlarged and pedunculated type I gastri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378368
BMJ Case Reports; Odisho T, Shi D et. al.

Aug 21st, 2021 - Three distinct gastric carcinoid (GC) tumour types have been described based on differing biological behaviour and prognoses. Type I GC tumours account for the vast majority (70%-80%), are associated with chronic atrophic gastritis and have a low ...

Neoplasms of the Endocrine Pancreas
https://emedicine.medscape.com/article/276943-overview

Jun 14th, 2021 - Practice Essentials Neoplasms of the endocrine pancreas can be divided into functional and nonfunctional varieties. Most pancreatic endocrine neoplasms discovered clinically are functional—that is, they secrete one or more hormonal products into t...

see more →

Drugs  434 results see all →

Clinicaltrials.gov  6 results

YF476 and Type II Gastric Carcinoids
https://clinicaltrials.gov/ct2/show/NCT02454075

Jan 29th, 2021 - This study will evaluate whether treatment with YF476 is safe and effective in reducing the size of type II gastric carcinoid tumours, or limiting the abnormal growth of gastric ECL cells, in patients with Zollinger-Ellison syndrome.

Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
https://clinicaltrials.gov/ct2/show/NCT01753024

Sep 6th, 2018 - Critically ill patients who is able to receive early enteral nutrition and estimated to stay in ICU at least four days are considered to enroll into this study. Exclusion criteria are age under 18 or over 80 years, pregnancy or breastfeeding, know...

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
https://clinicaltrials.gov/ct2/show/NCT00001191

Jul 2nd, 2017 - Patients with Zollinger-Ellison syndrome require continuous control of their gastric acid secretion or else severe complications of peptic ulcer disease will occur. This study investigates the long-term efficacy of the oral gastric acid antisecret...

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT00001228

Jul 2nd, 2017 - Heretofore morbidity and mortality in Zollinger-Ellison syndrome were caused by severe ulcer disease. The advent of specific drugs to cure ulcer disease now extends life until metastases from the non-B-islet cell tumor or other events cause death....

Treatment of Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001241

Jul 2nd, 2017 - This protocol describes the use of histamine H2-receptor antagonists to control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. It details which patients will be considered for treatment with these agents, the pretreatment...

see more →

News  16 results

Continue, Stop, or Taper the PPI?
https://www.medscape.com/viewarticle/920314_2

Oct 25th, 2019 - My Take: It's Time for a Change. Do You Agree? The patient may not like it, but it's worth at least trying to taper his PPI at this time, with a goal of stopping regular PPI dosing altogether. Like many others, this patient is using his PPI as chr...

Improper Proton Pump Inhibitor Prescriptions Criticized
https://www.medscape.com/viewarticle/913377

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...

Improper Proton Pump Inhibitor Prescriptions Criticized
https://www.staging.medscape.com/viewarticle/913377

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...

April 2019 - Question 2
https://www.mdedge.com/gihepnews/article/197788/april-2019-question-2?channel=29259

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

DDSEP® 8 Quick Quiz Question 2
https://www.mdedge.com/gihepnews/article/197788/ddsepr-8-quick-quiz-question-2

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

see more →

Patient Education  4 results see all →